US81221K1088
US81221K1088
Seaport Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 87.294.000 | 52.416.000 | 66.5% | |
| Operating Income | -87.294.000 | -52.416.000 | 66.5% |
| Pretax Income | -74.108.000 | -46.879.000 | 58.1% |
| Net Income Common Stockholders | -74.881.000 | -46.879.000 | 59.7% |
| -- | -- | -- | |
| -- | -- | -- |